Breaking News Instant updates and real-time market news.

2021-04-06 08:56:32 AEL American Equity $32.53 / +0.545 (+1.70%) 08:56 04/06/21 04/06 08:56 04/06/21 08:56	American Equity price target raised to $36 from $33 at RBC Capital RBC Capital analyst Mark Dwelle raised the firm's price target on American Equity to $36 from $33 and keeps an Outperform rating on the shares. The price target increase tracks the broadly higher valuations observed across the life insurance sector in response to rising treasury yields, the analyst tells investors in a research note, though he is also lowering his Q1 EPS view by 25c to 61c as a result of assumed higher average cash balances throughout Q1 amid reinsurance transactions that the company previously announced.
AEL American Equity $32.53 / +0.545 (+1.70%) 03/31/21 Citi American Equity price target raised to $33 from $31 at Citi 03/03/21 JPMorgan American Equity reinstated with a Neutral at JPMorgan 02/19/21 Truist American Equity price target raised to $36 from $30 at Truist 01/15/21 Raymond James American Equity upgraded to Outperform from Market Perform at Raymond James

2021-04-06 08:56:32

AEL

American Equity

$32.53 / +0.545 (+1.70%)

08:56

04/06/21

04/06

08:56

04/06/21

08:56

American Equity price target raised to $36 from $33 at RBC Capital

RBC Capital analyst Mark Dwelle raised the firm's price target on American Equity to $36 from $33 and keeps an Outperform rating on the shares. The price target increase tracks the broadly higher valuations observed across the life insurance sector in response to rising treasury yields, the analyst tells investors in a research note, though he is also lowering his Q1 EPS view by 25c to 61c as a result of assumed higher average cash balances throughout Q1 amid reinsurance transactions that the company previously announced.

AEL American Equity

$32.53 / +0.545 (+1.70%)

03/31/21 Citi: American Equity price target raised to $33 from $31 at Citi

03/03/21 JPMorgan: American Equity reinstated with a Neutral at JPMorgan

02/19/21 Truist: American Equity price target raised to $36 from $30 at Truist

01/15/21 Raymond James: American Equity upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Conference/Events	Rackspace Technology to host business news update conference call » 15:47 04/14/21 04/14 15:47 04/14/21 15:47 RXT Rackspace Technology $25.53 / +0.46 (+1.83%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/18/21 Rackspace Technology drops 8% to $22.80 after FY21 EPS view misses estimates 01/19/21 Rackspace Technology enters partnership with SNP Schneider-Neureither & Partner 12/03/20 Rackspace reports achieving AWS Travel and Hospitality Competency status 12/03/20 Rackspace to support launch of Professional Services in AWS marketplace RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 04/01/21 William Blair William Blair starts Rackspace with Outperform, sees 30% upside 03/31/21 William Blair Rackspace Technology initiated with an Outperform at William Blair 01/25/21 Oppenheimer Rackspace Technology initiated with an Outperform at Oppenheimer 09/01/20 BMO Capital Rackspace Technology price target raised to $25 from $23 at BMO Capital RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/18/21 Rackspace Technology sees FY21 EPS 95c-$1.05, consensus $1.11 02/18/21 Rackspace Technology reports Q4 EPS 26c, consensus 23c 11/10/20 Rackspace Technology sees FY20 EPS 79c-81c, consensus 79c 11/10/20 Rackspace Technology reports Q3 EPS 19c, consensus 18c 05 Aug RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 03/19/21 Rackspace change-in-control plan worth noting, Dealreporter says RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Pre-market Movers 02/18/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 05/12/21 Rackspace Technology, Inc. RXT Rackspace Technology $25.53 / +0.46 (+1.83%) 03/19/21 Unusually active option classes on open March 19th 12/08/20 Largest borrow rate increases among liquid names
Hot Stocks	PPD trading halted, volatility trading pause 15:47 04/14/21 04/14 15:47 04/14/21 15:47 PPD PPD $39.16 / +0.81 (+2.11%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PPD PPD $39.16 / +0.81 (+2.11%) 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment 02/18/21 PPD awarded US Army study to help develop PTSD drugs PPD PPD $39.16 / +0.81 (+2.11%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi PPD PPD $39.16 / +0.81 (+2.11%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B 17 Sep PPD PPD $39.16 / +0.81 (+2.11%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein 04/28/21 PPD - PPD 04/23/21 PPD, Inc.
Recommendations	Teleperformance price target raised to EUR 370 from EUR 340 at UBS » 15:47 04/14/21 04/14 15:47 04/14/21 15:47 TLPFY Teleperformance $198.77 / +3.83 (+1.96%) UBS analyst Bilal Aziz… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLPFY Teleperformance $198.77 / +3.83 (+1.96%) 04/13/21 Morgan Stanley Teleperformance price target raised to EUR 370 from EUR 350 at Morgan Stanley 04/13/21 JPMorgan Teleperformance price target raised to EUR 370 from EUR 340 at JPMorgan 04/13/21 AlphaValue Teleperformance upgraded to Add from Reduce at AlphaValue 03/17/21 Morgan Stanley Teleperformance price target raised to EUR 350 from EUR 340 at Morgan Stanley
Recommendations	Symrise price target raised to EUR 121 from EUR 118 at UBS » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SYIEY Symrise $32.58 / +1.1 (+3.49%) UBS analyst Geoff Haire… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SYIEY Symrise $32.58 / +1.1 (+3.49%) 11/23/20 Sensient to sell fragrance business to Symrise, terms not disclosed SYIEY Symrise $32.58 / +1.1 (+3.49%) 03/12/21 Berenberg Symrise price target lowered to EUR 106 from EUR 109 at Berenberg 03/11/21 DZ Bank Symrise upgraded to Hold from Sell at DZ Bank 03/10/21 JPMorgan Symrise price target lowered to EUR 90 from EUR 98 at JPMorgan 01/18/21 Morgan Stanley Symrise downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations	Schaeffler price target raised to EUR 8.50 from EUR 6.50 at Deutsche Bank » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SCFLF Schaeffler $9.65 / + (+0.00%) Deutsche Bank analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SCFLF Schaeffler $9.65 / + (+0.00%) 03/22/21 JPMorgan Schaeffler price target raised to EUR 9 from EUR 8 at JPMorgan 03/09/21 Morgan Stanley Schaeffler price target raised to EUR 5.30 from EUR 5.10 at Morgan Stanley 01/27/21 Berenberg Schaeffler price target raised to EUR 7.90 from EUR 7.20 at Berenberg 01/26/21 UBS Schaeffler price target raised to EUR 6.60 from EUR 6.30 at UBS

Recommendations	Serco Group price target raised to 165 GBp from 155 GBp at UBS » 15:46 04/14/21 04/14 15:46 04/14/21 15:46 SECCF Serco Group $1.94 / + (+0.00%) UBS analyst Rory McKenzie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SECCF Serco Group $1.94 / + (+0.00%) 03/01/21 Barclays Serco Group price target raised to 170 GBp from 150 GBp at Barclays 12/18/20 RBC Capital Serco Group price target lowered to 170 GBp from 180 GBp at RBC Capital 12/18/20 Berenberg Serco Group price target lowered to 185 GBp from 195 GBp at Berenberg 12/10/20 Barclays Serco Group price target lowered to 150 GBp from 165 GBp at Barclays
Recommendations	Randstad price target raised to EUR 55 from EUR 52.50 at UBS » 15:45 04/14/21 04/14 15:45 04/14/21 15:45 RANJY Randstad $37.59 / +0.59 (+1.59%) UBS analyst Rory McKenzie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RANJY Randstad $37.59 / +0.59 (+1.59%) 04/12/21 JPMorgan Randstad downgraded to Neutral from Overweight at JPMorgan 03/18/21 Morgan Stanley Randstad downgraded to Equal Weight from Overweight at Morgan Stanley 03/01/21 Deutsche Bank Randstad price target raised to EUR 63.40 from EUR 59 at Deutsche Bank 01/28/21 Jefferies Randstad downgraded to Underperform from Hold at Jefferies
Recommendations	LVMH price target raised to EUR 667 from EUR 640 at UBS » 15:44 04/14/21 04/14 15:44 04/14/21 15:44 LVMUY LVMH $147.85 / +6.86 (+4.87%) UBS analyst Helen Brand… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 15:19 Today Morgan Stanley LVMH price target raised to EUR 670 from EUR 625 at Morgan Stanley 15:11 Today RBC Capital LVMH price target raised to EUR 635 from EUR 600 at RBC Capital 15:08 Today JPMorgan LVMH price target raised to EUR 685 from EUR 625 at JPMorgan 10:46 Today Societe Generale LVMH price target raised to EUR 690 from EUR 615 at Societe Generale LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Johnson Matthey price target raised to 2,500 GBp from 2,300 GBp at UBS » 15:44 04/14/21 04/14 15:44 04/14/21 15:44 JMPLY Johnson Matthey $86.99 / + (+0.00%) UBS analyst Andrew Stott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research JMPLY Johnson Matthey $86.99 / + (+0.00%) 01/11/21 Johnson Matthey awarded multi-million pound agreement from SFC Energy 12/22/20 Johnson Matthey, Thyssenkrupp renew partnership for ammonia production JMPLY Johnson Matthey $86.99 / + (+0.00%) 03/24/21 Barclays Johnson Matthey price target lowered to 2,540 GBp from 2,570 GBp at Barclays 03/22/21 Jefferies Johnson Matthey initiated with a Buy at Jefferies 03/10/21 Credit Suisse Johnson Matthey price target raised to 3,500 GBp at Credit Suisse 03/03/21 Berenberg Johnson Matthey price target raised to 3,700 GBp from 3,200 GBp at Berenberg
Recommendations	Givaudan price target raised to CHF 4,260 from CHF 4,240 at UBS » 15:44 04/14/21 04/14 15:44 04/14/21 15:44 GVDNY Givaudan $83.40 / +1.66 (+2.03%) UBS analyst Patrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GVDNY Givaudan $83.40 / +1.66 (+2.03%) 04/12/21 Morgan Stanley Givaudan price target raised to CHF 3,500 from CHF 3,400 at Morgan Stanley 04/09/21 UBS Givaudan price target raised to CHF 4,240 from CHF 4,150 at UBS 04/01/21 JPMorgan Givaudan price target raised to CHF 3,710 from CHF 3,530 at JPMorgan 02/02/21 Societe Generale Givaudan downgraded to Sell from Hold at Societe Generale

Recommendations	Fuchs Petrolub price target raised to EUR 41 from EUR 40 at UBS » 15:43 04/14/21 04/14 15:43 04/14/21 15:43 FUPBY Fuchs Petrolub $12.97 / +0.16 (+1.25%) UBS analyst Eleanor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FUPBY Fuchs Petrolub $12.97 / +0.16 (+1.25%) 03/19/21 Credit Suisse Fuchs Petrolub price target lowered to EUR 37 from EUR 41 at Credit Suisse 03/19/21 Stifel Fuchs Petrolub upgraded to Hold from Sell at Stifel 03/10/21 Deutsche Bank Fuchs Petrolub price target lowered to EUR 47 from EUR 48 at Deutsche Bank 01/13/21 Berenberg Fuchs Petrolub price target raised to EUR 58 from EUR 50 at Berenberg
Periodicals	Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports » 15:43 04/14/21 04/14 15:43 04/14/21 15:43 MRNA Moderna $158.44 / +8.96 (+5.99%) , JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) Moderna (MRNA), looking… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 09:24 Today Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 06:56 Today Moderna says 14 different mRNA vaccine candidates entered into trials to date 06:54 Today Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 06:53 Today Moderna updates on clinical development of HIV vaccine candidates JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 09:33 Today EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine 04/13/21 J&J pauses vaccinations in all COVID-19 vaccine clinical trials 04/13/21 White House says J&J pause will not significantly impact vaccination plan 04/13/21 Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 10:59 Today Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 19 May MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 15:39 Today Moderna talking with Nexus to boost vaccine production, Reuters reports 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 11:59 Today Italy suspends distribution of J&J COVID-19 vaccines, Reuters reports 06:22 Today J&J vaccine pause threatens public opinion on COVID-19 vaccines, FT reports 06:17 Today CDC advisory panel to meet to discuss J&J Covid vaccine, WSJ reports 04/13/21 South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 12:14 Today Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/13/21 Fly Intel: Pre-market Movers 04/20/21 Johnson & Johnson - JNJ 05/07/21 Moderna - MRNA 08:00 Today Moderna 08:00 Today Moderna, Inc. 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. MRNA JNJ MRNA Moderna $158.44 / +8.96 (+5.99%) 10:45 Today Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish JNJ Johnson & Johnson $159.89 / +0.38 (+0.24%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Recommendations	Evonik price target raised to EUR 25 from EUR 23 at UBS » 15:43 04/14/21 04/14 15:43 04/14/21 15:43 EVKIF Evonik $35.92 / + (+0.00%) UBS analyst Geoff Haire… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EVKIF Evonik $35.92 / + (+0.00%) 12/07/20 Durect to sell Lactel product line to Evonik for $15M EVKIF Evonik $35.92 / + (+0.00%) 15:07 Today JPMorgan Evonik price target raised to EUR 32 from EUR 28.50 at JPMorgan 04/07/21 Societe Generale Evonik price target raised to EUR 36 from EUR 30 at Societe Generale 03/25/21 Morgan Stanley Evonik price target raised to EUR 35 from EUR 30 at Morgan Stanley 03/09/21 DZ Bank Evonik downgraded to Hold from Buy at DZ Bank
Recommendations	EssilorLuxottica price target raised to EUR 137 from EUR 136 at UBS » 15:42 04/14/21 04/14 15:42 04/14/21 15:42 ESLOY EssilorLuxottica $82.15 / -0.38 (-0.46%) UBS analyst Susy Tibaldi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ESLOY EssilorLuxottica $82.15 / -0.38 (-0.46%) 03/25/21 EssilorLuxottica agrees to acquire U.S. based lab network Walman 12/17/20 EssilorLuxottica declares interim dividend for FY20 of EUR 1.15 per share 12/17/20 EssilorLuxottica appoints Francesco Milleri as CEO, announces other changes ESLOY EssilorLuxottica $82.15 / -0.38 (-0.46%) 03/16/21 RBC Capital EssilorLuxottica price target raised to EUR 150 from EUR 146 at RBC Capital 03/16/21 Societe Generale EssilorLuxottica price target raised to EUR 134 from EUR 129 at Societe Generale 03/15/21 Morgan Stanley EssilorLuxottica price target raised to EUR 150 from EUR 137 at Morgan Stanley 03/15/21 UBS EssilorLuxottica price target raised to EUR 136 from EUR 133 at UBS ESLOY EssilorLuxottica $82.15 / -0.38 (-0.46%) 11/03/20 EssilorLuxottica reports Q3 revenue EUR 4.085B, down 5.2% y/y
Recommendations	Elementis price target raised to 140 GBp from 130 GBp at UBS » 15:42 04/14/21 04/14 15:42 04/14/21 15:42 EMNSF Elementis $1.77 / -0.08 (-4.32%) UBS analyst Andrew Stott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals EMNSF Elementis $1.77 / -0.08 (-4.32%) 12/10/20 Minerals Technologies does not intend to make offer to Elementis under Rule 2.7 11/25/20 Minerals Technologies confirms second rejected approach to Elementis board 11/12/20 Minerals Technologies confirms rejected approach to Elementis board EMNSF Elementis $1.77 / -0.08 (-4.32%) 02/25/21 Credit Suisse Elementis price target raised to 150 GBp from 99 GBp at Credit Suisse 01/25/21 Morgan Stanley Elementis price target lowered to 136 GBp from 138 GBp at Morgan Stanley 01/20/21 HSBC Elementis downgraded to Reduce from Hold at HSBC 11/27/20 Morgan Stanley Elementis initiated with an Overweight at Morgan Stanley EMNSF Elementis $1.77 / -0.08 (-4.32%) 11/11/20 Elementis received PE approach earlier in year, no talks ongoing, Sky News says

Recommendations	Croda International price target raised to 6,500 GBp from 6,400 GBp at UBS » 15:40 04/14/21 04/14 15:40 04/14/21 15:40 COIHY Croda International $46.76 / +0.47 (+1.02%) UBS analyst Andrew Stott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research COIHY Croda International $46.76 / +0.47 (+1.02%) 03/26/21 UBS Croda International price target raised to 6,400 GBp from 6,300 GBp at UBS 03/23/21 JPMorgan Croda price target lowered to 5,500 GBp from 5,700 GBp at JPMorgan 03/04/21 Berenberg Croda price target raised to 7,400 GBp from 7,200 GBp at Berenberg 03/03/21 Barclays Croda International price target raised to 6,000 GBp from 5,650 GBp at Barclays
Periodicals	Moderna talking with Nexus to boost vaccine production, Reuters reports 15:39 04/14/21 04/14 15:39 04/14/21 15:39 MRNA Moderna $158.30 / +8.82 (+5.90%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $158.30 / +8.82 (+5.90%) 09:24 Today Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 06:56 Today Moderna says 14 different mRNA vaccine candidates entered into trials to date 06:54 Today Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 06:53 Today Moderna updates on clinical development of HIV vaccine candidates MRNA Moderna $158.30 / +8.82 (+5.90%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study MRNA Moderna $158.30 / +8.82 (+5.90%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $158.30 / +8.82 (+5.90%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says MRNA Moderna $158.30 / +8.82 (+5.90%) 12:14 Today Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 05/07/21 Moderna - MRNA 08:00 Today Moderna 08:00 Today Moderna, Inc. 04/28/21 Moderna, Inc. MRNA Moderna $158.30 / +8.82 (+5.90%) 10:45 Today Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish
Recommendations	Clariant price target raised to CHF 20.50 from CHF 20 at UBS » 15:39 04/14/21 04/14 15:39 04/14/21 15:39 CLZNY Clariant $21.48 / +0.57 (+2.73%) UBS analyst Patrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals CLZNY Clariant $21.48 / +0.57 (+2.73%) 03/18/21 Societe Generale Clariant downgraded to Hold from Buy at Societe Generale 03/18/21 Societe Generale Clariant downgraded to Hold from Buy at Societe Generale 02/18/21 UBS Clariant price target raised to CHF 20 from CHF 19 at UBS 10/30/20 UBS Clariant price target lowered to CHF 16 from CHF 19 at UBS CLZNY Clariant $21.48 / +0.57 (+2.73%) 11/25/20 Clariant to eliminate 1,000 jobs, Bloomberg reports
Hot Stocks	Thor Industries, Winnebago rise after LCI Industries pre-announces sales beat » 15:37 04/14/21 04/14 15:37 04/14/21 15:37 THO Thor Industries $139.33 / +2.39 (+1.75%) , WGO Winnebago $77.89 / +0.83 (+1.08%) , LCII LCI Industries $141.00 / +4.17 (+3.05%) Shares of RV makers Thor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options THO WGO LCII THO Thor Industries $139.33 / +2.39 (+1.75%) 03/09/21 Thor Industries says its managing through temporary supply chain issues 12/21/20 Thor Industries CEO: We're always an opportunistic buyer 12/21/20 Thor Industries acquires Tiffin Motor Homes for $300M 12/08/20 Thor Industries expects to achieve continued growth in 2021 WGO Winnebago $77.89 / +0.83 (+1.08%) 03/24/21 Winnebago CEO 'optimistic' about retail, wholesale conditions for rest of year 03/18/21 Winnebago appoints Jacqueline Woods, Kevin Bryant to board of directors 03/04/21 Winnebago, National Park Foundation partner to advance outdoor equity 12/08/20 Winnebago releases 2020 corporate responsibility report LCII LCI Industries $141.00 / +4.17 (+3.05%) 15:18 Today LCI Industries trading resumes 14:28 Today LCI Industries trading halted, news pending 02/25/21 Lippert promotes Eileen Pruitt to Deputy CHRO, Senior Legal Counsel 12/22/20 LCI Industries CEO sells 10,000 common shares THO WGO LCII THO Thor Industries $139.33 / +2.39 (+1.75%) 03/10/21 Truist Thor Industries price target raised to $145 from $135 at Truist 03/10/21 BMO Capital Thor Industries price target raised to $160 from $125 at BMO Capital 03/10/21 Wedbush Thor Industries price target raised to $137 from $107 at Wedbush 02/02/21 Truist Thor Industries price target raised to $135 from $120 at Truist WGO Winnebago $77.89 / +0.83 (+1.08%) 03/25/21 BMO Capital Winnebago price target raised to $90 from $88 at BMO Capital 03/25/21 Truist Winnebago price target raised to $95 from $82 at Truist 03/25/21 Baird Winnebago price target raised to $85 from $75 at Baird 02/04/21 Wedbush Winnebago price target raised to $77 from $70 at Wedbush LCII LCI Industries $141.00 / +4.17 (+3.05%) 09/25/20 Northcoast LCI Industries upgraded to Buy from Neutral at Northcoast 09/22/20 CJS Securities LCI Industries upgraded to Outperform from Market Perform at CJS Securities 07/15/20 CL King LCI Industries price target raised to $134 from $121 at CL King 07/06/20 Citi LCI Industries initiated with a Neutral at Citi THO WGO LCII THO Thor Industries $139.33 / +2.39 (+1.75%) 03/09/21 Thor Industries reports Q2 EPS $2.38, consensus $1.55 12/08/20 Thor Industries reports Q1 EPS $2.05, consensus $1.56 12/07/20 Notable companies reporting before tomorrow's open 12/07/20 Notable companies reporting before tomorrow's open WGO Winnebago $77.89 / +0.83 (+1.08%) 03/24/21 Winnebago reports Q2 adjusted EPS $2.12, consensus $1.41 12/18/20 Winnebago reports Q1 adjusted EPS $1.69, consensus 98c 10/21/20 Winnebago reports Q4 adjusted EPS $1.45, consensus 90c 10/20/20 Notable companies reporting before tomorrow's open LCII LCI Industries $141.00 / +4.17 (+3.05%) 15:06 Today LCI Industries sees Q1 revenue $1.0B,consensus $880.28M 02/09/21 LCI Industries reports Q4 EPS $1.92, consensus $1.79 11/02/20 LCI Industries reports Q3 adj. EPS $2.72, consensus $2.42 THO WGO LCII THO Thor Industries $139.33 / +2.39 (+1.75%) 03/09/21 Fly Intel: Pre-market Movers 12/08/20 Fly Intel: Pre-market Movers WGO Winnebago $77.89 / +0.83 (+1.08%) 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Pre-market Movers 10/21/20 Fly Intel: Pre-market Movers LCII LCI Industries $141.00 / +4.17 (+3.05%) 02/03/21 Fly Intel: After-Hours Movers 05/20/21 LCI Industries THO THO Thor Industries $139.33 / +2.39 (+1.75%) 03/08/21 Call spread sale in Thor Industries rolls January position
Recommendations	Chr. Hansen price target raised to DKK 625 from DKK 615 at UBS » 15:25 04/14/21 04/14 15:25 04/14/21 15:25 CHYHY Chr. Hansen $24.29 / +0.28 (+1.17%) UBS analyst Patrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events CHYHY Chr. Hansen $24.29 / +0.28 (+1.17%) 01/15/21 Barclays Chr. Hansen price target lowered to DKK 470 from DKK 484 at Barclays 01/15/21 DNB Markets Chr. Hansen upgraded to Hold from Sell at DNB Markets 01/07/21 Danske Bank Chr. Hansen upgraded to Buy from Hold at Danske Bank 12/03/20 JPMorgan Chr. Hansen price target raised to DKK 500 from DKK 495 at JPMorgan 04/15/21 Chr. Hansen - CHYHY

Recommendations	Ashtead Group price target raised to 4,600 GBp from 2,950 GBp at UBS » 15:25 04/14/21 04/14 15:25 04/14/21 15:25 ASHTY Ashtead Group $252.06 / -2.17 (-0.85%) UBS analyst Rory McKenzie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ASHTY Ashtead Group $252.06 / -2.17 (-0.85%) 03/15/21 RBC Capital Ashtead Group price target raised to 3,800 GBp from 3,200 GBp at RBC Capital 03/04/21 JPMorgan Ashtead Group price target raised to 4,300 GBp from 3,500 GBp at JPMorgan 03/03/21 Morgan Stanley Ashtead Group price target raised to 3,540 GBp from 3,230 GBp at Morgan Stanley 02/24/21 Redburn Ashtead Group initiated with a Neutral at Redburn
Conference/Events	Shadow Open Market Committee to hold a virtual meeting » 15:25 04/14/21 04/14 15:25 04/14/21 15:25 Federal Reserve Vice… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Arkema price target raised to EUR 107 from EUR 100 at UBS » 15:24 04/14/21 04/14 15:24 04/14/21 15:24 ARKAY Arkema $122.76 / -0.88 (-0.71%) UBS analyst Geoff Haire… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARKAY Arkema $122.76 / -0.88 (-0.71%) 04/12/21 JPMorgan Arkema price target raised to EUR 110 from EUR 104 at JPMorgan 03/09/21 Stifel Arkema upgraded to Buy from Hold at Stifel 03/03/21 Berenberg Arkema price target raised to EUR 102 from EUR 94 at Berenberg 03/01/21 Kepler Cheuvreux Arkema upgraded to Buy from Hold at Kepler Cheuvreux
Recommendations	AkzoNobel price target raised to EUR 97 from EUR 89 at UBS » 15:24 04/14/21 04/14 15:24 04/14/21 15:24 AKZOY AkzoNobel $39.35 / +0.57 (+1.47%) UBS analyst Geoff Haire… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AKZOY AkzoNobel $39.35 / +0.57 (+1.47%) 01/28/21 AkzoNobel submits proposal to acquire Tikkurila at EUR 1.4B 01/18/21 AkzoNobel offers to acquire Tikkurila for EUR 1.4B, invites negotiation AKZOY AkzoNobel $39.35 / +0.57 (+1.47%) 02/23/21 UBS AkzoNobel price target lowered to EUR 89 from EUR 91 at UBS 01/19/21 Deutsche Bank AkzoNobel downgraded to Hold from Buy at Deutsche Bank 01/14/21 Berenberg AkzoNobel price target raised to EUR 98 from EUR 96 at Berenberg 01/14/21 Berenberg PPG upgraded to Buy with $165 price target at Berenberg 04/21/21 AkzoNobel - AKZOY
Recommendations	Adecco price target raised to CHF 57.50 from CHF 55 at UBS » 15:24 04/14/21 04/14 15:24 04/14/21 15:24 AHEXY Adecco $35.42 / +0.24 (+0.68%) UBS analyst Bilal Aziz… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AHEXY Adecco $35.42 / +0.24 (+0.68%) 04/12/21 JPMorgan Adecco downgraded to Neutral from Overweight at JPMorgan 03/29/21 AlphaValue Adecco upgraded to Reduce from Sell at AlphaValue 03/18/21 Morgan Stanley Adecco price target raised to CHF 66.50 from CHF 62 at Morgan Stanley 03/16/21 HSBC Adecco downgraded to Hold from Buy at HSBC

Events

Earnings calls, analyst events, roadshows and more

Today at 15:45

Federal Reserve’s New Policy Framework Government Event

Virtual Event
AFMD
Today at 16:05

Affimed - AFMD Conference Calls
BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

American Equity price target raised to $36 from $33 at RBC Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access